EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unveiling the future: precision pharmacovigilance in the era of personalized medicine

Lurdes Silva, Teresa Pacheco, Emília Araújo, Rita J Duarte, Inês Ribeiro-Vaz, Renato Ferreira-da-Silva

International Journal of Clinical Pharmacy · 2024-06 · 46 (3) · 755-760

DOI: 10.1007/s11096-024-01709-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Pharmacy, online erschienen am 28.02.2024. Verfasst von Lurdes Silva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy of the University of Porto, Porto, Portugal. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Pharmacogenetics, Pharmacovigilance, Precision Medicine. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia, Universidade do Porto.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the era of personalized medicine, pharmacovigilance faces new challenges and opportunities, demanding a shift from traditional approaches. This article delves into the evolving landscape of drug safety monitoring in the context of personalized treatments. We aim to provide a succinct reflection on the intersection of tailored therapeutic strategies and vigilant pharmacovigilance practices. We discuss the integration of pharmacogenetics in enhancing drug safety, illustrating how genetic profiling aids in predicting drug responses and adverse reactions. Emphasizing the importance of phase IV—post-marketing surveillance, we explore the limitations of pre-marketing trials and the necessity for a comprehensive approach to drug safety. The article discusses the pivotal role of pharmacogenetics in pre-exposure risk management and the redefinition of pharmacoepidemiological methods for post-exposure surveillance. We highlight the significance of integrating patient-specific genetic profiles in creating personalized medication leaflets and the use of advanced computational methods in data analysis. Additionally, we examine the ethical, privacy, and data security challenges inherent in precision medicine, emphasizing their implications for patient consent and data management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Related Side Effects and Adverse ReactionsPharmacogeneticsPharmacovigilancePrecision MedicineHumansProduct Surveillance, Postmarketing

Stichwörter der Autor:innen

Drug safetyPatient outcomesPersonalized medicinePharmacogenomicsPharmacovigilancePrecision medicine

Autor:innen und Institutionen

  • Faculty of Pharmacy of the University of Porto, Porto, Portugal.
  • Palliative Care Service, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
  • Center for Health Technology and Services Research, Associate Laboratory RISE - Health Research Network (CINTESIS@RISE), Porto, Portugal.
  • Pharmacovigilance, Bayer Portugal, Lisbon, Portugal.
  • Porto Pharmacovigilance Centre, Faculty of Medicine of the University of Porto, Porto, Portugal.
  • Department of Community Medicine, Health Information and Decision, Faculty of Medicine of the University of Porto, Porto, Portugal.

Förderung

  • Fundação para a Ciência e a Tecnologia
  • Universidade do Porto

Zitieren

APA

Silva, L., Pacheco, T., Araújo, E., Duarte, R. J., Ribeiro-Vaz, I., & Ferreira-da-Silva, R. (2024). Unveiling the future: precision pharmacovigilance in the era of personalized medicine. International Journal of Clinical Pharmacy, 46(3), 755-760. https://doi.org/10.1007/s11096-024-01709-x

Vancouver

Silva L, Pacheco T, Araújo E, Duarte RJ, Ribeiro-Vaz I, Ferreira-da-Silva R. Unveiling the future: precision pharmacovigilance in the era of personalized medicine. International Journal of Clinical Pharmacy. 2024;46(3):755-760. doi:10.1007/s11096-024-01709-x

BibTeX
@article{Silva2024,
  author = {Silva, Lurdes and Pacheco, Teresa and Araújo, Emília and Duarte, Rita J and Ribeiro-Vaz, Inês and Ferreira-da-Silva, Renato},
  title = {Unveiling the future: precision pharmacovigilance in the era of personalized medicine},
  journal = {International Journal of Clinical Pharmacy},
  year = {2024},
  volume = {46},
  number = {3},
  pages = {755--760},
  doi = {10.1007/s11096-024-01709-x}
}
Kostenlos starten →